LENZ Therapeutics, Inc., a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, has announced certain preliminary unaudited financial results for the fourth quarter ended December 31, 2025 and recent corporate updates. Approved by the FDA in August 2025, VIZZ is a once-daily aceclidine-based eye drop for the treatment of age-related presbyopia….
The Contact Lens Institute (CLI) has announced the winners of its 2025 Contact Lens Institute Culture Awards, recognizing five U.S. and Canadian eyecare teams and individuals. These honorees were selected for their successful efforts in cultivating contact lens cultures that lead to improved patient experiences and better business outcomes, the group advised. According to the…
The Eye Consortium (TEC), an alliance group for independent practices, has formed a new Elite Vendor partnership with Bausch + Lomb to help advance TEC’s ongoing commitment to deliver programs and resources that help the alliance’s member doctors elevate both the patient experience and practice profitability. “In response to the overwhelming interest from our membership,…
Prevent Blindness, has announced that Matt MacDonald, president and global head of managed care, EyeMed Vision Care, was appointed chair of its board of directors on November 14, at the 2025 Prevent Blindness annual board meeting here. MacDonald succeeds Jim McGrann, CEO of Advancing Eyecare, who was named an emeritus member of the board. At…
Scotlens, a leading custom contact lens manufacturer, has unveiled its refreshed brand identity at the Hospital and Specialty Optometrists Conference (8–9 November 2025). The rebrand follows its acquisition by Contact Lens Precision Laboratories (CLPL) six months ago and aligns Scotlens with CLPL and sister company Ultravision, which rebranded in 2024. “This integration strengthens our mission…
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its ONE by ONE Recycling program has collected a total of 691,180 pounds, or 114,037,136 units, of used contact lens, eyecare and lens care materials in the United States. The program, created in collaboration with international recycling leader TerraCycle, continues to…
LENZ Therapeutics, Inc. the pharmaceutical company focused on the commercialization of recently FDA-approved VIZZ (aceclidine ophthalmic solution) 1.44%, has announced financial results for the third quarter ending September 30, 2025, as well as recent corporate highlights. Highlighted among those was the FDA approval in late July of VIZZ, an aceclidine-based eye drop for the treatment…
BostonSight, a nonprofit eye health care organization that advances the treatment of irregular corneas and ocular surface disease through specialty lenses, announced today that Karen Carrasquillo, OD, Ph.D., FAAO, FSLS, FBCLA, has been appointed to the new role of chief innovation and education officer, effective immediately. She formerly served as senior vice president, clinical and…
Optometry Giving Sight (OGS) recently honored the memory of the organization’s founder, professor Brien Holden, Ph.D., with the inaugural Brien Holden Founders Award dinner, the organization said in an announcement. Holden, a leader in expanding access to vision care worldwide who passed away in 2015, established OGS in 2003 in collaboration with the World Council…
The Centre for Ocular Research & Education (CORE) has published the latest edition of Contact Lens Update, dedicated to rapidly accelerating interest in pre-myopia that is influencing risk assessment, early intervention, and myopia management among clinicians. Guidance from four expert contributors includes strategies, technologies, and clinical insights for the pediatric and primary eye care communities….